Skip to content
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. (NDRA) Q1 2024 Earnings

NDRA·Reported May 14, 2024·After market close

Diluted EPS came in at $-454.55, missed the $-0.27 consensus by $454.28.

Diluted EPS
$-454.55missed by $454.28
Consensus: $-0.27
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q1 2024

Q1 2024 Earnings FAQ

Common questions about ENDRA Life Sciences Inc.'s Q1 2024 earnings report.

ENDRA Life Sciences Inc. (NDRA) reported Q1 2024 earnings on May 14, 2024 after market close.

ENDRA Life Sciences Inc. reported diluted EPS of $-454.55 for Q1 2024.

EPS missed the consensus estimate of $-0.27 by $454.28.

You can read the 10-Q periodic report (0001654954-24-006243) directly on SEC EDGAR. The filing index links above go to sec.gov.